dc.contributor |
Landspítali |
dc.contributor.author |
Jónsdóttir, Ingileif |
dc.date.accessioned |
2022-03-08T01:01:04Z |
dc.date.available |
2022-03-08T01:01:04Z |
dc.date.issued |
2021-03 |
dc.identifier.citation |
Jónsdóttir , I 2021 , ' Bylting í þróun bóluefna ' , Læknablaðið , bind. 107 , nr. 3 , bls. 119 . https://doi.org/10.17992/lbl.2021.03.623 |
dc.identifier.issn |
0023-7213 |
dc.identifier.other |
36961915 |
dc.identifier.other |
3518af56-79ef-475e-a8fc-30f984272140 |
dc.identifier.other |
85102321977 |
dc.identifier.other |
33625376 |
dc.identifier.other |
unpaywall: 10.17992/lbl.2021.03.623 |
dc.identifier.other |
researchoutputwizard: hdl.handle.net/2336/621700 |
dc.identifier.uri |
https://hdl.handle.net/20.500.11815/2931 |
dc.format.extent |
1 |
dc.format.extent |
2509124 |
dc.format.extent |
119 |
dc.language.iso |
is |
dc.relation.ispartofseries |
Læknablaðið; 107(3) |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.subject |
COVID-19 |
dc.subject |
Bóluefni |
dc.subject |
Ritstjórnargreinar |
dc.subject |
Vaccines |
dc.subject |
COVID-19 |
dc.subject |
Vaccines/adverse effects |
dc.subject |
Humans |
dc.subject |
Biomedical Research |
dc.subject |
Bóluefni |
dc.subject |
Bóluefni |
dc.subject |
COVID-19 |
dc.subject |
Vaccines |
dc.subject |
Almenn læknisfræði |
dc.title |
Bylting í þróun bóluefna |
dc.title.alternative |
Revolutionary vaccine development |
dc.type |
/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/comment |
dc.identifier.doi |
10.17992/lbl.2021.03.623 |
dc.relation.url |
http://www.scopus.com/inward/record.url?scp=85102321977&partnerID=8YFLogxK |
dc.relation.url |
https://www.laeknabladid.is/tolublod/2021/03/nr/7656 |
dc.contributor.department |
Læknadeild |
dc.contributor.department |
Rannsóknaþjónusta |